Parma consensus statement on metabolic disruptors

Jerrold J Heindel¹, Frederick S Vom Saal², Bruce Blumberg³, Patrizia Bovolin⁴, Gemma Calamandrei⁵, Graziano Ceresini⁶, Barbara A Cohn⁷, Elena Fabbri⁸, Laura Gioiosa⁹, Christopher Kassotis², Juliette Legler¹⁰, Michele La Merrill¹¹, Laura Rizzir¹², Ronit Machtinger¹³, Alberto Mantovani¹⁴, Michelle A Mendez¹⁵, Luisa Montanini¹⁶, Laura Molteni¹⁷, Susan C Nagel¹⁸, Stefano Parmigiani¹⁹, Giancarlo Panzica²⁰, Silvia Paterlini²⁰, Valentina Pomatto⁴, Jérôme Ruzzin²¹, Giorgio Sartor²², Thaddeus T Schug²³, Maria E Street²⁴, Alexander Suvorov², Riccardo Volpi²⁵, R Thomas Zoeller²⁶, Paola Palanza⁹

Affiliations

¹ Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. heindelj@niehs.nih.gov.
² Division of Biological Sciences, University of Missouri, Columbia, MO, USA.
³ Department of Developmental and Cell Biology, University of California, Irvine, CA, USA.
⁴ Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy.
⁵ Department of Cell Biology and Neurosciences, Insituto Superiore di Sanita, Rome, Italy.
⁶ Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
⁷ Public Health Institute, Berkeley, CA, USA.
⁸ Interdepartment Center for Environmental Science Research, University of Bologna, Ravenna, Italy.
⁹ Department of Neuroscience, University of Parma, Parma, Italy.
¹⁰ Department of Toxicology and Environmental Health, VU University Amsterdam, Amsterdam, Netherlands.
¹¹ Department of Environmental Toxicology, University of California, Davis, CA, USA.
¹² Department of Health Sciences, University of Milano-Bicocca, Monza, Italy.
¹³ Sheba Medical Center and Tel-Aviv University, Tel -Aviv, Israel.
¹⁴ Instituto Superiore di Sanita, Rome, Italy.
¹⁵ School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
¹⁶ Department of Pediatrics, University of Parma, Parma, Italy.
¹⁷ University of Milano-Bicocca, Monza, Italy.
¹⁸ Department of Obstetrics, Gynecology and Women's Health, University of Missouri, Columbia, MO, USA.
¹⁹ Faculty of Medicine, University of Parma, Parma, Italy.
²⁰ Department of Neuroscience and Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Turin, Italy.
²¹ Department of Biology, University of Bergen, Bergen, Norway.
²² Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
²³ Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
²⁴ Department of Pediatrics, University Hospital, Parma, Italy.
²⁵ Department of Internal Medicine, University of Parma, Parma, Italy.
²⁶ Department of Biology, University of Massachusetts, Amherst, MA, USA.

PMID: 26092037
PMCID: PMC4473834
DOI: 10.1186/s12940-015-0042-7

Parma consensus statement on metabolic disruptors

Jerrold J Heindel et al. Environ Health. 2015.

. 2015 Jun 20:14:54.

doi: 10.1186/s12940-015-0042-7.

Authors

Affiliations

¹ Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. heindelj@niehs.nih.gov.
² Division of Biological Sciences, University of Missouri, Columbia, MO, USA.
³ Department of Developmental and Cell Biology, University of California, Irvine, CA, USA.
⁴ Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy.
⁵ Department of Cell Biology and Neurosciences, Insituto Superiore di Sanita, Rome, Italy.
⁶ Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
⁷ Public Health Institute, Berkeley, CA, USA.
⁸ Interdepartment Center for Environmental Science Research, University of Bologna, Ravenna, Italy.
⁹ Department of Neuroscience, University of Parma, Parma, Italy.
¹⁰ Department of Toxicology and Environmental Health, VU University Amsterdam, Amsterdam, Netherlands.
¹¹ Department of Environmental Toxicology, University of California, Davis, CA, USA.
¹² Department of Health Sciences, University of Milano-Bicocca, Monza, Italy.
¹³ Sheba Medical Center and Tel-Aviv University, Tel -Aviv, Israel.
¹⁴ Instituto Superiore di Sanita, Rome, Italy.
¹⁵ School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
¹⁶ Department of Pediatrics, University of Parma, Parma, Italy.
¹⁷ University of Milano-Bicocca, Monza, Italy.
¹⁸ Department of Obstetrics, Gynecology and Women's Health, University of Missouri, Columbia, MO, USA.
¹⁹ Faculty of Medicine, University of Parma, Parma, Italy.
²⁰ Department of Neuroscience and Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Turin, Italy.
²¹ Department of Biology, University of Bergen, Bergen, Norway.
²² Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
²³ Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
²⁴ Department of Pediatrics, University Hospital, Parma, Italy.
²⁵ Department of Internal Medicine, University of Parma, Parma, Italy.
²⁶ Department of Biology, University of Massachusetts, Amherst, MA, USA.

PMID: 26092037
PMCID: PMC4473834
DOI: 10.1186/s12940-015-0042-7

Erratum in

Correction to: Parma consensus statement on metabolic disruptors.
Heindel JJ, Vom Saal FS, Blumberg B, Bovolin P, Calamandrei G, Ceresini G, Cohn BA, Fabbri E, Gioiosa L, Kassotis C, Legler J, La Merrill M, Rizzi L, Machtinger R, Mantovani A, Mendez MA, Montanini L, Molteni L, Nagel SC, Parmigiani S, Panzica G, Paterlini S, Pomatto V, Ruzzin J, Sartor G, Schug TT, Street ME, Suvorov A, Volpi R, Zoeller RT, Palanza P. Heindel JJ, et al. Environ Health. 2017 Dec 6;16(1):130. doi: 10.1186/s12940-017-0343-0. Environ Health. 2017. PMID: 29212512 Free PMC article.

Abstract

A multidisciplinary group of experts gathered in Parma Italy for a workshop hosted by the University of Parma, May 16-18, 2014 to address concerns about the potential relationship between environmental metabolic disrupting chemicals, obesity and related metabolic disorders. The objectives of the workshop were to: 1. Review findings related to the role of environmental chemicals, referred to as "metabolic disruptors", in obesity and metabolic syndrome with special attention to recent discoveries from animal model and epidemiology studies; 2. Identify conclusions that could be drawn with confidence from existing animal and human data; 3. Develop predictions based on current data; and 4. Identify critical knowledge gaps and areas of uncertainty. The consensus statements are intended to aid in expanding understanding of the role of metabolic disruptors in the obesity and metabolic disease epidemics, to move the field forward by assessing the current state of the science and to identify research needs on the role of environmental chemical exposures in these diseases. We propose broadening the definition of obesogens to that of metabolic disruptors, to encompass chemicals that play a role in altered susceptibility to obesity, diabetes and related metabolic disorders including metabolic syndrome.

PubMed Disclaimer

References

1. O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12. doi: 10.1111/obr.12229. - DOI - PubMed
1. Heindel JJ, vom Saal FS. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol. 2009;304:90–6. doi: 10.1016/j.mce.2009.02.025. - DOI - PubMed
1. Ogden CL, Carroll MD, Flegal KM. Prevalence of obesity in the United States. JAMA. 2014;312(2):189–90. doi: 10.1001/jama.2014.6228. - DOI - PubMed
1. Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med. 1999;159(13):1450–6. doi: 10.1001/archinte.159.13.1450. - DOI - PubMed
1. Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, Bell R, Badaru A, Talton JW, Crume T, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778–86. doi: 10.1001/jama.2014.3201. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

R01 ES023316/ES/NIEHS NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Parma consensus statement on metabolic disruptors

Affiliations

Parma consensus statement on metabolic disruptors

Authors

Affiliations

Erratum in

Abstract

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources